Thank you for attending the 2018 Breast Cancer Coordinated Care (BC3) Conference, at the Grand Hyatt Washington in Washington, DC.
We look forward to seeing you again in 2020!
Breast cancer is the most common cancer affecting women. Diagnosis and treatments are part of the practice of a wide number of medical specialists and there are national initiatives calling for a multidisciplinary approach to the care of breast cancer patients. The multiple components and aspects of the treatment of breast cancer require a high level of coordinated care among different specialties. This coordination becomes even more challenging because of the rapid evolution of new treatment modalities and is especially important due to of the possibility of improved outcomes both in terms of curing the disease, as well as maintaining the physical and psychological well-being of the patient.
The meeting will offer presentations and panel discussions on a number of currently important topics in the local treatment of breast cancer including oncoplastic surgery and the role of prophylactic mastectomy. Experts in the field will cover the state of partial breast irradiation, intraoperative radiation therapy, timing and indications for post-mastectomy radiation, and neoadjuvant chemotherapy and its role in restaging breast cancer. Additionally, the program will examine nipple-sparing mastectomy, both therapeutic and prophylactic, treatment of breast cancer in a previously augmented breast, the status of MRI screening for breast cancer, the effects of reconstruction on the delivery of post-mastectomy radiation, and the evolving role of alloplastic materials in breast reconstruction. It will also cover in depth the state-of-the-art emerging field of lymphatic surgery to treat lymphedema. The latest updates on national trends and data on financial toxicity related to cancer care will also be discussed.
This three-day symposium will evaluate and discuss different models for coordination of breast cancer care from major centers across the United States. The meeting’s intent is not only to educate the faculty and attendees about the wide range of options available for breast cancer coordinated care but also to encourage the development of more standardized treatment strategies and protocols for the local treatment of breast cancer. Participating in the three-day symposium will give you access to:
- Three-day education agenda with live lectures, presentations, panel discussions and interactive Q&A sessions
- Poster abstracts authors’ session
- Multiple symposia
Shawna C. Willey, MD
MedStar Regional Breast Health Program MedStar Georgetown University Hospital Washington, DC
David H. Song, MD, MBA
MedStar Georgetown University Hospital Washington, DC